Can Geriatric Assessment Measures Be Used to Determine Cancer Treatment Vulnerability in Nongeriatric Patients?
Concurrent chemoradiation, the mainstay of treatment in locally advanced head and neck cancer, is a challenging endeavor even for the fittest of individuals. On one hand, it confers superior therapeutic outcomes compared with either chemotherapy or radiation alone; on the other hand, the high-intensity treatment is associated with substantial treatment toxicity that in turn leads to treatment schedule interruption or incompletion, hospitalization, or even death.1-4
Source: International Journal of Radiation Oncology * Biology * Physics - Category: Radiology Authors: Kavita V. Dharmarajan, Supriya G. Mohile Tags: Clinical Investigation Source Type: research
More News: Biology | Cancer | Cancer & Oncology | Chemotherapy | Geriatrics | Head and Neck Cancer | Physics | Radiology | Toxicology